GENE ONLINE|News &
Opinion
Blog

PerkinElmer
M&A PerkinElmer
PerkinElmer Sells Three of its Businesses for $2.45 Billion
2022-08-03
Deals
PerkinElmer Makes its Biggest Buy Yet Forking Out $5.25 Billion for Latest Acquisition
2021-07-30
M&A CRISPR
Why is PerkinElmer Buying Horizon Discovery?
2020-11-02
Technology CRISPR
Scientists Use CRISPR To Fight Duchenne Muscular Dystrophy
2020-01-29
Ranking & Reports Active Pharmaceutical Ingredient
Weekly Top 5 in China (0217-0223)
2019-02-22
LATEST
The Fight Against Hard-to-Treat Cancers : Bold Bets on a Multifaceted Approach
2025-05-19
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
2025-05-19
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
Boehringer Ingelheim and Tempus AI Partner in Multi-Year Collaboration to Enhance Oncology Drug Development
2025-05-15
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15
Tribal Leaders Warn Senators: Federal Health Funding Cuts Threaten Native American Health.
2025-05-14
READ MORE
EVENT
2025-05-26
2025 Antibody Therapeutic & Frontiers in Biomedical Sciences Conference
Taipei, Taiwan
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top